Unknown

Dataset Information

Disruption of sialic acid metabolism drives tumor growth by augmenting CD8+ T cell apoptosis.


ABSTRACT: Sialylated glycan structures are known for their immunomodulatory capacities and their contribution to tumor immune evasion. However, the role of aberrant sialylation in colorectal cancer and the consequences of complete tumor desialylation on anti-tumor immunity remain unstudied. Here, we report that CRISPR/Cas9-mediated knock out of the CMAS gene, encoding a key enzyme in the sialylation pathway, in the mouse colorectal cancer MC38 cell line completely abrogated cell surface expression of sialic acids (MC38-Sianull ) and, unexpectedly, significantly increased in vivo tumor growth compared to the control MC38-MOCK cells. This enhanced tumor growth of MC38-Sianull cells could be attributed to decreased CD8+ T cell frequencies in the tumor microenvironment o

SUBMITTER: Cornelissen LAM 

PROVIDER: S-EPMC6519079 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature